Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 2Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Leukemia-Lymphoma, Adult T-Cell 1HTLV-I Infections 1

Interventions

Peripheral Blood Stem Cell Transplantation 9Cyclophosphamide 9fludarabine phosphate 8Whole-Body Irradiation 7Tacrolimus 6Mycophenolic Acid 6Busulfan 6Epoetin Alfa 5Melphalan 4Cyclosporine 4Antilymphocyte Serum 4Methotrexate 3Etoposide 3Darbepoetin alfa 3fludarabine 2Sirolimus 2Patient Reported Outcome Measures 2Morphine 2Methylprednisolone 2Mesna 2Interferon-alpha 2Filgrastim 2Carboplatin 2Bone Marrow Transplantation 2tanespimycin 1sargramostim 1pyroxamide 1peginterferon alfa-2b 1ferrous sulfate 1ferric gluconate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × peginterferon alfa-2b × Lymphoid × Clear all
NCT00854581 2018-04-17

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

University of Miami

Phase 4 Terminated
13 enrolled 15 charts
LymphoidOther hematologic neoplasmOther neoplasm

Lymphoma, Precancerous Conditions, HTLV-I Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡